Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol for pain and inflammation after third molar extraction
RBR-8rv93wnPhase 1Not yet recruiting
- Sponsor
- Universidade Federal de Uberlândia
- Start
- Jan 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in postoperative pain and inflammation comparing Cannabidiol oil with Placebo oil (2 arms). Planned start Jan 2024; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
postoperative paininflammation
Beyond the preview
Go deeper on RBR-8rv93wn.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8rv93wn.